Coherus Oncology, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CHRS | CGEN | HURA | PYXS | CRVS | CMPX | |
|---|---|---|---|---|---|---|
| Market cap | 159.14M | 196.08M | 121.08M | 240.11M | 845.42M | 168.83M |
| P/E (TTM) | — | 5.3 | — | — | — | — |
| Forward P/E | -1.6 | -5.6 | -3.1 | -1.8 | -9.4 | -1.7 |
| Price/book | 2.6 | 2.2 | 6.6 | 11.2 | 3.8 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −39.41% | −1.90% | −24.90% | −37.77% | +42.76% | −78.39% |
| Today | −3.74% | −2.82% | −3.06% | −0.99% | −4.47% | −5.59% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CHRS news ›Head to Head Survey: Coherus Oncology (NASDAQ:CHRS) vs. Molecular Partners (NASDAQ:MOLN)
Posted by Mitch Edgeman on Oct 2nd, 2026 Coherus Oncology (NASDAQ:CHRS – Get Free Report) and Molecular Partners (NASDAQ:MOLN – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the…
Head-To-Head Survey: Coherus Oncology (NASDAQ:CHRS) vs. Capricor Therapeutics (NASDAQ:CAPR)
Posted by Mitch Edgeman on Oct 2nd, 2026 Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) and Coherus Oncology (NASDAQ:CHRS – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com2
-
manilatimes.net1
-
marketscreener.com1
-
quiverquant.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.